Review of the literature and proposed guidelines for the use of oral ribavirin as postexposure prophylaxis for Lassa fever.

@article{Bausch2010ReviewOT,
  title={Review of the literature and proposed guidelines for the use of oral ribavirin as postexposure prophylaxis for Lassa fever.},
  author={Daniel G. Bausch and Christiane M. Hadi and Sheik Humarr Khan and Juan J. L. Lertora},
  journal={Clinical infectious diseases : an official publication of the Infectious Diseases Society of America},
  year={2010},
  volume={51 12},
  pages={1435-41}
}
Lassa fever is an acute viral hemorrhagic illness; the virus is endemic in West Africa and also of concern with regard to bioterrorism. Transmission of Lassa virus between humans may occur through direct contact with infected blood or bodily secretions. Oral administration of the antiviral drug ribavirin is often considered for postexposure prophylaxis, but no systematically collected data or uniform guidelines exist for this indication. Furthermore, the relatively low secondary attack rates… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 39 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 86 references

Arenavirus Infections

  • D Enria, JN Mills, R Flick
  • 2006
2 Excerpts

Similar Papers

Loading similar papers…